Vice President, Gene Editing Core
Intellia Therapeutics, Inc.
August 29, 2026
Full-time
Remote friendly (Cambridge, MA)
Worldwide
Clinical Research and Development
Role: Vice President, Gene Editing Core, leading a cross-functional team to advance genome editing therapies through innovative research and platform development. Responsibilities: oversee project planning, execution of assays for gene editing outcomes, platform improvements, and integration of new technologies; manage genomics and RNA labs, support preclinical development, and collaborate with computational teams. Lead external partnerships, ensure regulatory compliance, and foster a culture of collaboration and innovation. Manage budget and resources for genomics core functions. Supervisory duties include directing and developing a team of scientists, promoting high performance and professional growth. Requirements: PhD in molecular biology, genomics, or related field; minimum 8 years (PhD) or 10 years (Masterโs/Bachelorโs) of relevant experience; 7+ years in team management; extensive expertise in genomics technologies including NGS, ddPCR, single-cell genomics; strong bioinformatics, experimental design, and regulatory knowledge. Preferred skills: leadership in biotech/pharma, experience with gene editing platforms, off-target analysis, structural variants, and in vivo therapeutic programs. High-value: focus on gene editing therapies, platform innovation, early research support, and cross-disciplinary collaboration. Work setup: not specified, likely hybrid or on-site in a research environment.